Danielle E. Mor

900 total citations
15 papers, 638 citations indexed

About

Danielle E. Mor is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Danielle E. Mor has authored 15 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Danielle E. Mor's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Alzheimer's disease research and treatments (4 papers) and Neurological disorders and treatments (4 papers). Danielle E. Mor is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Alzheimer's disease research and treatments (4 papers) and Neurological disorders and treatments (4 papers). Danielle E. Mor collaborates with scholars based in United States, Switzerland and Spain. Danielle E. Mor's co-authors include Harry Ischiropoulos, Coleen T. Murphy, Rachel Kaletsky, Salman Sohrabi, William Keyes, Neal S. Gould, Gary W. Miller, Vrinda Kalia, Kim A. Caldwell and Preetika Gupta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Danielle E. Mor

14 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle E. Mor United States 11 363 216 182 181 86 15 638
Paul C. Marcogliese United States 14 290 0.8× 375 1.7× 217 1.2× 177 1.0× 106 1.2× 22 773
Lorena de Mena Spain 15 212 0.6× 362 1.7× 197 1.1× 176 1.0× 71 0.8× 22 626
Gabriela Caraveo United States 9 466 1.3× 394 1.8× 294 1.6× 277 1.5× 101 1.2× 13 938
Jonathan C. Grima United States 10 406 1.1× 517 2.4× 186 1.0× 178 1.0× 108 1.3× 10 903
Mark Franko United States 10 184 0.5× 260 1.2× 210 1.2× 276 1.5× 144 1.7× 12 764
Valeriya Baru United States 6 139 0.4× 241 1.1× 120 0.7× 185 1.0× 109 1.3× 6 503
Luís M. A. Oliveira Portugal 12 520 1.4× 298 1.4× 328 1.8× 278 1.5× 93 1.1× 13 931
Lavinia Palamiuc France 12 240 0.7× 238 1.1× 77 0.4× 95 0.5× 45 0.5× 13 585
Goun Je United States 12 263 0.7× 256 1.2× 176 1.0× 100 0.6× 108 1.3× 19 609
Yanpeng Yuan China 10 225 0.6× 192 0.9× 150 0.8× 83 0.5× 68 0.8× 26 475

Countries citing papers authored by Danielle E. Mor

Since Specialization
Citations

This map shows the geographic impact of Danielle E. Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle E. Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle E. Mor more than expected).

Fields of papers citing papers by Danielle E. Mor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle E. Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle E. Mor. The network helps show where Danielle E. Mor may publish in the future.

Co-authorship network of co-authors of Danielle E. Mor

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle E. Mor. A scholar is included among the top collaborators of Danielle E. Mor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle E. Mor. Danielle E. Mor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cisterna, Bruno A., Kristen Skruber, Mitchell T. Butler, et al.. (2024). Prolonged depletion of profilin 1 or F-actin causes an adaptive response in microtubules. The Journal of Cell Biology. 223(7). 2 indexed citations
2.
Mor, Danielle E.. (2024). Keeping neuronal activity in check: a novel role for α-synuclein serine-129 phosphorylation in the healthy brain. Trends in Biochemical Sciences. 49(5). 382–383.
3.
Mor, Danielle E., et al.. (2023). Gut-to-Brain α-Synuclein Transmission in Parkinson’s Disease: Evidence for Prion-like Mechanisms. International Journal of Molecular Sciences. 24(8). 7205–7205. 25 indexed citations
4.
Mor, Danielle E., et al.. (2022). Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson’s in vivo models. Life Science Alliance. 5(11). e202201366–e202201366. 18 indexed citations
5.
McIntyre, Lauren M., Alison M. Morse, Rachel Kaletsky, et al.. (2022). GAIT-GM integrative cross-omics analyses reveal cholinergic defects in a C. elegans model of Parkinson’s disease. Scientific Reports. 12(1). 3268–3268. 3 indexed citations
6.
Sohrabi, Salman, Danielle E. Mor, Rachel Kaletsky, William Keyes, & Coleen T. Murphy. (2021). High-throughput behavioral screen in C. elegans reveals Parkinson’s disease drug candidates. Communications Biology. 4(1). 203–203. 26 indexed citations
7.
Mor, Danielle E., Salman Sohrabi, Rachel Kaletsky, et al.. (2020). Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria. Proceedings of the National Academy of Sciences. 117(42). 26438–26447. 109 indexed citations
8.
Mor, Danielle E. & Coleen T. Murphy. (2020). Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease. SHILAP Revista de lepidopterología. 4. 117–120. 7 indexed citations
9.
Mor, Danielle E., et al.. (2019). The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration. Movement Disorders. 34(2). 167–179. 68 indexed citations
10.
Yao, Vicky, Rachel Kaletsky, William Keyes, et al.. (2018). An integrative tissue-network approach to identify and test human disease genes. Nature Biotechnology. 36(11). 1091–1099. 43 indexed citations
11.
Mor, Danielle E. & Harry Ischiropoulos. (2018). The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease. SHILAP Revista de lepidopterología. 12. 2211761552–2211761552. 15 indexed citations
12.
Mor, Danielle E., Elpida Tsika, Joseph R. Mazzulli, et al.. (2017). Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration. Nature Neuroscience. 20(11). 1560–1568. 171 indexed citations
13.
Mor, Danielle E., et al.. (2015). Dynamic structural flexibility of α-synuclein. Neurobiology of Disease. 88. 66–74. 65 indexed citations
14.
Gould, Neal S., et al.. (2014). Evidence of Native α-Synuclein Conformers in the Human Brain. Journal of Biological Chemistry. 289(11). 7929–7934. 59 indexed citations
15.
Hartman, Nathaniel W., et al.. (2010). CXCL12-Mediated Guidance of Migrating Embryonic Stem Cell-Derived Neural Progenitors Transplanted into the Hippocampus. PLoS ONE. 5(12). e15856–e15856. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026